Biofrontera Inc (BFRI)

NASDAQ
1.80
-0.06(-3.23%)
After Hours
1.84
+0.04(+2.22%)
- Real-time Data
  • Volume:
    112,336
  • Day's Range:
    1.77 - 1.94
  • 52 wk Range:
    1.77 - 14.63

BFRI Overview

Prev. Close
1.86
Day's Range
1.77-1.94
Revenue
29.11M
Open
1.9
52 wk Range
1.77-14.63
EPS
-3.43
Volume
112,336
Market Cap
34.12M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,627,958
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
18,954,749
Next Earnings Date
30 Aug 2022
What is your sentiment on Biofrontera?
or
Market is currently closed. Voting is open during market hours.

Biofrontera Inc News

Biofrontera Inc Analysis

Biofrontera Inc Company Profile

Biofrontera Inc Company Profile

Employees
56

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company’s licensor’s medical device; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi, a prescription cream for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellSell
Technical IndicatorsBuyStrong SellStrong SellStrong SellSell
SummaryNeutralStrong SellStrong SellStrong SellSell
  • Short squeeze, pass along
    0
    • Too volatile for me. I traded in out suffered losses!
      0